Bilateral Bispectral Index, Asymmetries and Post-operative Delirium
Bilateral Bispectral Index and Asymmetries in High Risk Patients for Posteoperative Delirium: An Observational, Prospective, Exploratory Study
IRCCS Azienda Ospedaliero-Universitaria di Bologna
84 participants
Jul 7, 2020
OBSERVATIONAL
Conditions
Summary
The primary objective of the study is to describe the value of interhemispheric asymmetry (ASYM), during the different intra- and peri-operative phases, in those patients who develop or do not develop post-operative delirium (POD) during the first 30 post-operative days and postoperative cognitive disfunction (POCD) in the first 90 post-operative days, in a population undergoing head\&neck and plastic surgery with a priori increased probability of POD.
Eligibility
Inclusion Criteria5
- Patients, undergoing head\&neck surgery, who have at least 3 of the following criteria (to establish "a priori" increased risk of POD):
- Age> 70;
- Male sex; or ASA III;
- Smoker;
- High blood pressure;
Exclusion Criteria15
- ASA IV, V or ASA IE, IIE, IIIE (patients with anesthetic risk ASA>III and those undergoing urgent-emergency surgery will be excluded from the study);
- Past positive medical history for:
- Stroke;
- Dementia;
- Cerebral aneurysm;
- Intracranial mass;
- Head trauma;
- Epilepsy;
- Diabetes mellitus;
- Previous neurosurgical intervention;
- Psychiatric illnesses requiring chronic treatment;
- Patients undergoing surgery in the previous two weeks;
- Patients whose hospitalization duration is estimated to be less than five days;
- Lack of understanding of the Italian language or English;
- Age <18 years.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In patients undergoing surgery and general anesthesia, the investigators want to examine -using bilateral BIS monitor- synthetic electroencephalographic differences between the two cerebral hemispheres (ASYM) to evaluate any correlation with the development of POD and POCD in the post-operative period.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06761573